Stock Earnings

Question 1

What are Akero Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Akero Therapeutics Inc has a total asset of $825, Net loss of $-252

Question 2

What are the key financial ratios for AKRO?

Accepted Answer

Akero Therapeutics Inc's Current ratio is 11, has a Net margin is 0, sales per share of $0.

Question 3

How is Akero Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Akero Therapeutics Inc data is not available.

Question 4

Is Akero Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Akero Therapeutics Inc has a net loss of $-252

Question 5

Does Akero Therapeutics Inc have any liabilities?

Accepted Answer

yes, Akero Therapeutics Inc has liability of 75

Question 6

How many outstanding shares for Akero Therapeutics Inc?

Accepted Answer

Akero Therapeutics Inc has a total outstanding shares of 72.38

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	43	37	31	29	19	15
Research & Development	286	247	141	85	81	64
Operating Expenses	330	285	172	115	100	80
Other Non Operating Income (Expenses)	--	--	--	3	--	--
Pretax Income	-292	-252	-151	-112	-100	-79
Income Tax Expense	--	--	--	0	0	0
Net Income	-292	-252	-151	-112	-100	-79
Net Income Growth	24%	67%	35%	12%	27%	84%
Shares Outstanding (Diluted)	82	67.13	52.56	38.98	34.83	31.46
Shares Change (YoY)	18%	28%	35%	12%	11%	109%
EPS (Diluted)	-3.57	-3.75	-2.88	-2.87	-2.89	-2.52
EPS Growth	5%	30%	1%	-1%	15%	-13%
Free Cash Flow	-250	-231	-145	-92	-79	-70
Free Cash Flow Per Share	-3.04	-3.44	-2.75	-2.36	-2.26	-2.22
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	-285	-172	-115	-100	-80
EBITDA Margin	--	0%	0%	0%	0%	0%
D&A For EBITDA	--	0	0	0	0	0
EBIT	-330	-285	-172	-115	-100	-80
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	0%	0%	0%

Akero Therapeutics Inc (AKRO) Price